Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers
On January 23, 2021, Allena Pharmaceuticals, Inc. (the "Company") adopted the
Allena Pharmaceuticals, Inc. 2021 Inducement Equity Plan (the "Inducement
Plan"), pursuant to which the Company reserved 1,600,000 shares of its common
stock for issuance under the Inducement Plan to be used exclusively for grants
of awards to individuals who were not previously employees of the Company, as an
inducement material to the individual's entry into employment with the Company
within the meaning of Nasdaq Listing Rule 5635(c)(4). The Inducement Plan was
approved by the Board of Directors of the Company without stockholder approval
pursuant to Nasdaq Listing Rule 5635(c)(4).
The foregoing description of the terms of the Inducement Plan is not intended to
be complete and is qualified in its entirety by reference to the Inducement
Plan, a copy of which is included hereto as Exhibit 10.1 and incorporated herein
by reference.
© Edgar Online, source Glimpses
ALLENA PHARMACEUTICALS, INC. 
